The National Institute of Health and Clinical Excellence (NICE) has published new guidance for the month of January 2013. This month there is one clinical guideline and one technology appraisal that impact upon primary care.
The Psychosis and schizophrenia in children and young people guideline offers evidence-based advice on the recognition and management of psychosis and schizophrenia in children and young people under 18.
The Hyperplasia (benign prostatic) - tadalafil technology appraisal was terminated and the treatment with tadalafil is not recommended for the treatment of symptoms associated with benign prostatic hyperplasia. The manufacturer failed to make an evidence submission.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.